App DescriptionImportant: This application is downloaded on your device and it securely enables instant and uninterrupted access wherever you are as it does not rely on a network connection while in use. The application is a single edition only; to stay updated it is recommended to purchase the forthcoming editions as they are revised twice yearly. Next edition (BNF64) is expected to be released in October 2012.
This essential reference provides up-to-date, practical guidance on prescribing, dispensing, and administering medicines.
The BNF evaluates clinical evidence from diverse sources with information validated by a network of clinical experts and published under the authority of a Joint Formulary Committee.
The BNF reflects current best practice as well as legal and professional guidelines relating to the uses of medicines.
•Guidance on the drug management of common conditions
•Details of medicines prescribed within the UK with special reference to their uses, cautions, contra-indications, side-effects, doses and relative costs
•Guidance on prescribing, monitoring, dispensing and administering medicines
It enables healthcare professionals to maximise the benefits of drug treatment and minimise the risks, while encouraging good compliance with treatment.
Updated every six months, the BNF evaluates clinical evidence from diverse sources. The information is validated by a network of clinical experts and is published under the authority of a Joint Formulary Committee. The BNF reflects current best practice as well as legal and professional guidelines relating to the use of medicines.
Authors: British Medical Association and Royal Pharmaceutical Society of Great Britain
Important information: This app will be removed from sale when newer edition have been released.
MedHand Mobile Libraries offers a SUBSCRIPTION FREE application without edition upgrade.
MedHand delivers what you need, trusted knowledge at the point of care!
MedHand are presenting latest editions from renowned publishers such as Oxford University Press, McGraw-Hill, Royal Pharmaceutical Society, PDR Network LLC, Wiley and more.
April 19, 2012 Initial Release